Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

ZBP2 facilitates binding of ZBP1 to beta-actin mRNA during transcription.

Pan F, Hüttelmaier S, Singer RH, Gu W.

Mol Cell Biol. 2007 Dec;27(23):8340-51. Epub 2007 Sep 24. Erratum in: Mol Cell Biol. 2009 May;29(9):2481.

2.

ZBP1 enhances cell polarity and reduces chemotaxis.

Lapidus K, Wyckoff J, Mouneimne G, Lorenz M, Soon L, Condeelis JS, Singer RH.

J Cell Sci. 2007 Sep 15;120(Pt 18):3173-8.

3.

Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma.

Köbel M, Weidensdorfer D, Reinke C, Lederer M, Schmitt WD, Zeng K, Thomssen C, Hauptmann S, Hüttelmaier S.

Oncogene. 2007 Nov 29;26(54):7584-9. Epub 2007 Jun 4.

PMID:
17546046
4.

CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.

Noubissi FK, Elcheva I, Bhatia N, Shakoori A, Ougolkov A, Liu J, Minamoto T, Ross J, Fuchs SY, Spiegelman VS.

Nature. 2006 Jun 15;441(7095):898-901.

PMID:
16778892
5.

Transcription under the control of nuclear Arm/beta-catenin.

Städeli R, Hoffmans R, Basler K.

Curr Biol. 2006 May 23;16(10):R378-85. Review.

6.

RNA-binding IMPs promote cell adhesion and invadopodia formation.

Vikesaa J, Hansen TV, Jønson L, Borup R, Wewer UM, Christiansen J, Nielsen FC.

EMBO J. 2006 Apr 5;25(7):1456-68. Epub 2006 Mar 16.

7.

Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1.

Hüttelmaier S, Zenklusen D, Lederer M, Dictenberg J, Lorenz M, Meng X, Bassell GJ, Condeelis J, Singer RH.

Nature. 2005 Nov 24;438(7067):512-5.

PMID:
16306994
8.

Gene expression profiling in single cells within tissue.

Capodieci P, Donovan M, Buchinsky H, Jeffers Y, Cordon-Cardo C, Gerald W, Edelson J, Shenoy SM, Singer RH.

Nat Methods. 2005 Sep;2(9):663-5.

9.

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.

Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M.

J Biol Chem. 2005 May 20;280(20):20086-93. Epub 2005 Mar 14.

10.

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A.

J Cell Biol. 2005 Feb 14;168(4):633-42.

11.

How and why does beta-actin mRNA target?

Condeelis J, Singer RH.

Biol Cell. 2005 Jan;97(1):97-110. Review.

PMID:
15601261
12.

VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins.

Yisraeli JK.

Biol Cell. 2005 Jan;97(1):87-96. Review.

PMID:
15601260
13.

Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS.

Cancer Res. 2004 Dec 1;64(23):8585-94.

14.

The Wnt signaling pathway in development and disease.

Logan CY, Nusse R.

Annu Rev Cell Dev Biol. 2004;20:781-810. Review.

PMID:
15473860
15.

Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.

Liao B, Patel M, Hu Y, Charles S, Herrick DJ, Brewer G.

J Biol Chem. 2004 Nov 19;279(47):48716-24. Epub 2004 Sep 8.

16.

Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.

Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J, Nielsen FC.

Mol Cell Biol. 2004 May;24(10):4448-64.

18.

Mammary tumor induction in transgenic mice expressing an RNA-binding protein.

Tessier CR, Doyle GA, Clark BA, Pitot HC, Ross J.

Cancer Res. 2004 Jan 1;64(1):209-14.

19.

Beta-catenin and Tcfs in mammary development and cancer.

Hatsell S, Rowlands T, Hiremath M, Cowin P.

J Mammary Gland Biol Neoplasia. 2003 Apr;8(2):145-58. Review.

PMID:
14635791
20.

CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.

Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, Andersen JA, Evangelou E, Dafni U, Pandis N, Trangas T.

Anticancer Res. 2003 May-Jun;23(3A):2179-83. Review.

PMID:
12894594
Items per page

Supplemental Content

Write to the Help Desk